Cutaneous pseudolymphoma-A review on the spectrum and a proposal for a new classification.
B-cell lymphoma
Borreliosis
T-cell lymphoma
clonality
cutaneous pseudolymphoma
infection
tattoo
Journal
Journal of cutaneous pathology
ISSN: 1600-0560
Titre abrégé: J Cutan Pathol
Pays: United States
ID NLM: 0425124
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
received:
04
01
2019
revised:
26
05
2019
accepted:
14
06
2019
pubmed:
27
6
2019
medline:
5
6
2020
entrez:
26
6
2019
Statut:
ppublish
Résumé
Cutaneous pseudolymphomas (PSLs) belong to a group of lymphocytic infiltrates that histopathologically and/or clinically simulate lymphomas. Different causative agents (e.g., Borrelia sp., injected substances, tattoo, arthropod bite) have been described, but in many cases no cause can be identified, hence the term idiopathic PSL. Clinicopathological correlation is important to make the diagnosis. Four main groups of cutaneous PSL can be distinguished based on histopathologic and/or clinical presentation: (a) nodular PSL; (b) pseudo-mycosis fungoides (pseudo-MF) and simulators of other CTCLs; (c) other PSL (representing distinct clinical entities); and (d) intravascular PSL. This article gives an overview of the histopathologic and clinical characteristics of cutaneous PSLs and proposes a new classification.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
76-97Informations de copyright
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Rijlaarsdam JU, Willemze R. Cutaneous pseudolymphomas: classification and differential diagnosis. Semin Dermatol. 1994;13(3):187-196.
Ploysangam T, Breneman DL, Mutasim DF. Cutaneous pseudolymphomas. J Am Acad Dermatol. 1998;38(6 Pt 1):877-895.
Mitteldorf C, Kempf W. Cutaneous pseudolymphoma. Surg Pathol Clin. 2017;10(2):455-476.
Miguel D, Peckruhn M, Elsner P. Treatment of cutaneous pseudolymphoma: a systematic review. Acta Derm Venereol. 2018;98(3):310-317.
Gilliam AC, Wood GS. Cutaneous lymphoid hyperplasias. Semin Cutan Med Surg. 2000;19(2):133-141.
Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375-2390.
Hammer E, Sangueza O, Suwanjindar P, White CR Jr, Braziel RM. Immunophenotypic and genotypic analysis in cutaneous lymphoid hyperplasias. J Am Acad Dermatol. 1993;28(3):426-433.
Bouloc A, Delfau-Larue MH, Lenormand B, et al. Polymerase chain reaction analysis of immunoglobulin gene rearrangement in cutaneous lymphoid hyperplasias. French study group for cutaneous lymphomas. Arch Dermatol. 1999;135(2):168-172.
Holm N, Flaig MJ, Yazdi AS, Sander CA. The value of molecular analysis by PCR in the diagnosis of cutaneous lymphocytic infiltrates. J Cutan Pathol. 2002;29(8):447-452.
Colli C, Leinweber B, Mullegger R, Chott A, Kerl H, Cerroni L. Borrelia burgdorferi-associated lymphocytoma cutis: clinicopathologic, immunophenotypic, and molecular study of 106 cases. J Cutan Pathol. 2004;31(3):232-240.
Mitteldorf C, Plumbaum H, Zutt M, Schön MP, Kaune KM. CD8-positive pseudolymphoma in lues maligna and HIV with monoclonal TCR-beta rearrangement. J Cutan Pathol. 2019;46(3):204-210.
van Vloten WA, Willemze R. The many faces of lymphocytoma cutis. J Eur Acad Dermatol Venereol. 2003;17(1):3-6.
Mitteldorf C, Geisinger E, Pleimes M, Schön MP, Kempf W. T-cell pseudolymphoma in recurrent herpes simplex virus infection. J Cutan Pathol. 2019. Epub ahead of print
Goodlad JR, Davidson MM, Hollowood K, Batstone P, Ho-Yen DO. Borrelia burgdorferi-associated cutaneous marginal zone lymphoma: a clinicopathological study of two cases illustrating the temporal progression of B. burgdorferi-associated B-cell proliferation in the skin. Histopathology. 2000;37(6):501-508.
Joseph D, Irukulla MM, Ahmed SF, Valiyaveettil D, Akram S. Radiotherapy in aggressive cutaneous pseudolymphoma: a case report and review of literature. Radiat Oncol J. 2016;34(1):76-80.
Tan LS, Oon HH, Lee JS, Chua SH. Successful treatment of tattoo-induced pseudolymphoma with sequential ablative fractional resurfacing followed by Q-switched Nd: YAG 532 nm laser. J Cutan Aesthet Surg. 2013;6(4):226-228.
Singletary HL, Selim MA, Olsen E. Subcutaneous interferon alfa for the treatment of cutaneous pseudolymphoma. Arch Dermatol. 2012;148(5):572-574.
Moulonguet I, Ghnassia M, Molina T, Fraitag S. Miliarial-type perifollicular B-cell pseudolymphoma (lymphocytoma cutis): a misleading eruption in two women. J Cutan Pathol. 2012;39(11):1016-1021.
Erickson SP, Nahmias Z, Rosman IS, Sternhell-Blackwell K, Musiek AC. Sustained remission of recalcitrant cutaneous lymphoid hyperplasia after thalidomide treatment. JAAD Case Rep. 2018;4(3):245-247.
Brodell RT, Santa Cruz DJ. Cutaneous pseudolymphomas. Dermatol Clin. 1985;3(4):719-734.
WHE C. Cutaneous lymphoid hyperplasia. Cancer. 1969;24:487-502.
Kutzner H, Kerl H, Pfaltz MC, Kempf W. CD123-positive plasmacytoid dendritic cells in primary cutaneous marginal zone B-cell lymphoma: diagnostic and pathogenetic implications. Am J Surg Pathol. 2009;33(9):1307-1313.
Kempf W, Kerl H, Kutzner H. CD123-positive plasmacytoid dendritic cells in primary cutaneous marginal zone B-cell lymphoma: a crucial role and a new lymphoma paradigm. Am J Dermatopathol. 2009;32(2):194-196.
Boudova L, Kazakov DV, Sima R, et al. Cutaneous lymphoid hyperplasia and other lymphoid infiltrates of the breast nipple: a retrospective clinicopathologic study of fifty-six patients. Am J Dermatopathol. 2005;27(5):375-386.
Nihal M, Mikkola D, Horvath N, et al. Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential. Hum Pathol. 2003;34(6):617-622.
Boer A, Tirumalae R, Bresch M, Falk TM. Pseudoclonality in cutaneous pseudolymphomas: a pitfall in interpretation of rearrangement studies. Br J Dermatol. 2008;159(2):394-402.
Golling P, Cozzio A, Dummer R, French L, Kempf W. Primary cutaneous B-cell lymphomas - clinicopathological, prognostic and therapeutic characterisation of 54 cases according to the WHO-EORTC classification and the ISCL/EORTC TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome. Leuk Lymphoma. 2008;49(6):1094-1103.
Cerroni L, Zöchling N, Pütz B, Kerl H. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol. 1997;24(8):457-461.
Li C, Inagaki H, Kuo TT, et al. Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathologic study of 24 Asian cases. Am J Surg Pathol. 2003;27(8):1061-1069.
Wood GS, Kamath NV, Guitart J, et al. Absence of Borrelia burgdorferi DNA in cutaneous B-cell lymphomas from the United States. J Cutan Pathol. 2001;28(10):502-507.
Baldassano MF, Bailey EM, Ferry JA, Harris NL, Duncan LM. Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features. Am J Surg Pathol. 1999;23(1):88-96.
Kempf W, Mitteldorf C. Pathologic diagnosis of cutaneous lymphomas. Dermatol Clin. 2015;33(4):655-681.
Leinweber B, Colli C, Chott A, Kerl H, Cerroni L. Differential diagnosis of cutaneous infiltrates of B lymphocytes with follicular growth pattern. Am J Dermatopathol. 2004;26(1):4-13.
Raess PW, Bagg A. The role of molecular pathology in the diagnosis of cutaneous lymphomas. Pathol Res Int. 2012;2012:913523.
Kash N, Fink-Puches R, Cerroni L. Cutaneous manifestations of B-cell chronic lymphocytic leukemia associated with borrelia burgdorferi infection showing a marginal zone B-cell lymphoma-like infiltrate. Am J Dermatopathol. 2011;33(7):712-715.
Levin C, Mirzamani N, Zwerner J, Kim Y, Schwartz EJ, Sundram U. A comparative analysis of cutaneous marginal zone lymphoma and cutaneous chronic lymphocytic leukemia. Am J Dermatopathol. 2012;34(1):18-23.
Grange F, Wechsler J, Guillaume JC, et al. Borrelia burgdorferi-associated lymphocytoma cutis simulating a primary cutaneous large B-cell lymphoma. J Am Acad Dermatol. 2002;47(4):530-534.
Kempf W, Flaig MJ, Kutzner H. Molecular diagnostics in infectious skin diseases. J Dtsch Dermatol Ges. 2013;11(Suppl 4):50-58.
Bertolotti A, Pham-Ledard A, Petrot D, et al. Two cases of proliferation of monoclonal and monotypic lymphocytes and plasma cells corresponding to acrodermatitis chronica atrophicans. Ann Dermatol Venereol. 2014;141(6-7):452-457.
Cetinozman F, Jansen PM, Willemze R. Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma. Am J Surg Pathol. 2012;36(1):109-116.
Kibbi AG, Scrimenti RJ, Koenig RR, Mihm MC Jr. A solitary nodule of the left cheek. Pseudolymphomatous folliculitis. Arch Dermatol. 1988;124(8):1272-1273. 1276.
Arai E, Okubo H, Tsuchida T, Kitamura K, Katayama I. Pseudolymphomatous folliculitis: a clinicopathologic study of 15 cases of cutaneous pseudolymphoma with follicular invasion. Am J Surg Pathol. 1999;23(11):1313-1319.
Kazakov DV, Belousova IE, Kacerovska D, et al. Hyperplasia of hair follicles and other adnexal structures in cutaneous lymphoproliferative disorders: a study of 53 cases, including so-called pseudolymphomatous folliculitis and overt lymphomas. Am J Surg Pathol. 2008;32(10):1468-1478.
Petersson F. Pseudolymphomatous folliculitis with marked lymphocytic folliculo- and focal epidermotropism--expanding the morphologic spectrum. Am J Dermatopathol. 2011;33(3):323-325.
Bergman R, Khamaysi Z, Sahar D, Ben-Arieh Y. Cutaneous lymphoid hyperplasia presenting as a solitary facial nodule: clinical, histopathological, immunophenotypical, and molecular studies. Arch Dermatol. 2006;142(12):1561-1566.
Leinweber B, Beltraminelli H, Kerl H, Cerroni L. Solitary small- to medium-sized pleomorphic T-cell nodules of undetermined significance: clinical, histopathological, immunohistochemical and molecular analysis of 26 cases. Dermatology. 2009;219(1):42-47.
Kempf W. Cutaneous CD30-positive lymphoproliferative disorders. Surg Pathol Clin. 2014;7(2):203-228.
Kempf W, Mitteldorf C, Karai LJ, Robson A. Lymphomatoid papulosis - making sense of the alphabet soup: a proposal to simplify terminology. J Dtsch Dermatol Ges. 2017;15(4):390-394.
Gonzalez LC, Murua MA, Perez RG, et al. CD30+ lymphoma simulating orf. Int J Dermatol. 2010;49(6):690-692.
Kempf W. CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators. J Cutan Pathol. 2006;33(Suppl 1):58-70.
Fukamachi S, Sugita K, Sawada Y, Bito T, Nakamura M, Tokura Y. Drug-induced CD30+ T cell pseudolymphoma. Eur J Dermatol. 2009;19(3):292-294.
Werner B, Massone C, Kerl H, Cerroni L. Large CD30-positive cells in benign, atypical lymphoid infiltrates of the skin. J Cutan Pathol. 2008;35(12):1100-1107.
Greisser J, Palmedo G, Sander C, et al. Detection of clonal rearrangement of T-cell receptor genes in the diagnosis of primary cutaneous CD30 lymphoproliferative disorders. J Cutan Pathol. 2006;33(11):711-715.
Lukowsky A, Muche JM, Sterry W, Audring H. Detection of expanded T cell clones in skin biopsy samples of patients with lichen sclerosus et atrophicus by T cell receptor-gamma polymerase chain reaction assays. J Invest Dermatol. 2000;115(2):254-259.
Klemke CD, Booken N, Weiss C, et al. Histopathological and immunophenotypical criteria for the diagnosis of sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) cutaneous lymphoma task force study of 97 cases. Br J Dermatol. 2015;173(1):93-105.
Boonk SE, Cetinozman F, Vermeer MH, Jansen PM, Willemze R. Differential expression of TOX by skin-infiltrating T cells in Sézary syndrome and erythrodermic dermatitis. J Cutan Pathol. 2015;42(9):604-609.
Gomez-Orbaneja J, Diez LI, Lozano JL, Salazar LC. Lymphomatoid contact dermatitis: a syndrome produced by epicutaneous hypersensitivity with clinical features and a histopathologic picture similar to that of mycosis fungoides. Contact Dermatitis. 1976;2(3):139-143.
Wolf IH, Cerroni L, Fink-Puches R, Kerl H. The morphologic spectrum of cutaneous pseudolymphomas. J Dtsch Dermatol Ges. 2005;3(9):710-720. quiz 721.
Magro CM, Daniels BH, Crowson AN. Drug induced pseudolymphoma. Semin Diagn Pathol. 2018;35(4):247-259.
Souteyrand P, d'Incan M. Drug-induced mycosis fungoides-like lesions. Curr Probl Dermatol. 1990;19:176-182.
Pulitzer MP, Nolan KA, Oshman RG, Phelps RG. CD30+ lymphomatoid drug reactions. Am J Dermatopathol. 2013;35(3):343-350.
Toonstra J, Henquet CJ, van Weelden H, van der Putte SC, van Vloten WA. Actinic reticuloid. A clinical photobiologic, histopathologic, and follow-u study of 16 patients. J Am Acad Dermatol. 1989;21(2 Pt 1):205-214.
Toonstra J. Actinic reticuloid. Semin Diagn Pathol. 1991;8(2):109-116.
Sbidian E, Battistella M, Rivet J, et al. Remission of severe CD8(+) cytotoxic T cell skin infiltrative disease in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis. 2010;51(6):741-748.
Bayal C, Büyükbani N, Seckin D, Yilmaz Z, Kempf W. Cutaneous atypical papular CD8+ lymphoproliferative disorder at acral sites in a renal transplant patient. Clin Exp Dermatol. 2017;42(8):902-905.
Ingen-Housz-Oro S, Sbidian E, Ortonne N, et al. HIV-related CD8+ cutaneous pseudolymphoma: efficacy of methotrexate. Dermatology. 2013;226(1):15-18.
Longacre TA, Foucar K, Koster F, Burgdorf W. Atypical cutaneous lymphoproliferative disorder resembling mycosis fungoides in AIDS. Report of a case with concurrent Kaposi's sarcoma. Am J Dermatopathol. 1989;11(5):451-456.
Egbers RG, Do TT, Su L, Helfrich YR, Gudjonsson JE. Rapid clinical change in lesions of atypical cutaneous lymphoproliferative disorder in an HIV patient: a case report and review of the literature. Dermatol Online J. 2011;17(9):4.
Kempf W, Kazakov DV, Hubscher E, Tinguely M. Cutaneous borreliosis with a T-cell-rich infiltrate and simultaneous involvement by B-cell chronic lymphocytic leukemia with t(14;18)(q32;q21). Am J Dermatopathol. 2015;37(9):715-718.
Kempf W, Kazakov DV, Kutzner H. Lobular panniculitis due to Borrelia burgdorferi infection mimicking subcutaneous panniculitis-like T-cell lymphoma. Am J Dermatopathol. 2013;35(2):e30-e33.
Mitteldorf C, Tronnier M. Histologic features of granulomatous skin diseases. J Dtsch Dermatol Ges. 2016;14(4):378-388.
Tomasini C, Moneghini L, Barbui AM. Chronic amastigote-negative cutaneous leishmaniasis: a clinical, histopathologic and molecular study of 27 cases with emphasis on atypical and pseudolymphomatous presentations. J Cutan Pathol. 2017;44(6):530-537.
Boer A, Blodorn-Schlicht N, Wiebels D, Steinkraus V, Falk TM. Unusual histopathological features of cutaneous leishmaniasis identified by polymerase chain reaction specific for Leishmania on paraffin-embedded skin biopsies. Br J Dermatol. 2006;155(4):815-819.
Boer A, Herder N, Blodorn-Schlicht N, Falk T. Herpes incognito most commonly is herpes zoster and its histopathologic pattern is distinctive! Am J Dermatopathol. 2006;28(2):181-186.
Lewin JM, Farley-Loftus R, Pomeranz MK. Herpes simplex virus-associated pseudolymphoma. Cutis. 2013;92(6):E1-E2.
Sbidian E, Battistella M, Legoff J, et al. Recalcitrant pseudotumoral anogenital herpes simplex virus type 2 in HIV-infected patients: evidence for predominant B-lymphoplasmocytic infiltration and immunomodulators as effective therapeutic strategy. Clin Infect Dis. 2013;57(11):1648-1655.
Hodak E, David M, Rothem A, Bialowance M, Sandbank M. Nodular secondary syphilis mimicking cutaneous lymphoreticular process. J Am Acad Dermatol. 1987;17(5 Pt 2):914-917.
Erfurt C, Lueftl M, Simon M Jr, Schuler G, Schultz ES. Late syphilis mimicking a pseudolymphoma of the skin. Eur J Dermatol. 2006;16(4):431-434.
Moon HS, Park K, Lee JH, Son SJ. A nodular syphilid presenting as a pseudolymphoma: mimicking a cutaneous marginal zone B-cell lymphoma. Am J Dermatopathol. 2009;31(8):846-848.
Flamm A, Parikh K, Xie Q, Kwon EJ, Elston DM. Histologic features of secondary syphilis: a multicenter retrospective review. J Am Acad Dermatol. 2015;73(6):1025-1030.
Yamashita M, Fujii Y, Ozaki K, et al. Human immunodeficiency virus-positive secondary syphilis mimicking cutaneous T-cell lymphoma. Diagn Pathol. 2015;10:185.
Toro JR, Sander CA, LeBoit PE. Persistent pigmented purpuric dermatitis and mycosis fungoides: simulant, precursor, or both? A study by light microscopy and molecular methods. Am J Dermatopathol. 1997;19(2):108-118.
Magro C, Crowson AN, Kovatich A, Burns F. Pityriasis lichenoides: a clonal T-cell lymphoproliferative disorder. Hum Pathol. 2002;33(8):788-795.
Citarella L, Massone C, Kerl H, Cerroni L. Lichen sclerosus with histopathologic features simulating early mycosis fungoides. Am J Dermatopathol. 2003;25(6):463-465.
Kempf W, Kazakov DV, Palmedo G, Fraitag S, Schaerer L, Kutzner H. Pityriasis lichenoides et varioliformis acuta with numerous CD30+ cells: a variant mimicking lymphomatoid papulosis and other cutaneous lymphomas. A clinicopathologic, immunohistochemical, and molecular biological study of 13 cases. Am J Surg Pathol. 2012;36(7):1021-1029.
Dereure O, Levi E, Kadin ME. T-cell clonality in pityriasis lichenoides et varioliformis acuta: a heteroduplex analysis of 20 cases. Arch Dermatol. 2000;136(12):1483-1486.
Mitteldorf C, Palmedo G, Kutzner H, et al. Diagnostic approach in lymphoplasmacytic plaque. J Eur Acad Dermatol Venereol. 2015;29(11):2206-2215.
Dayrit JF, Wang WL, Goh SG, Ramdial PK, Lazar AJ, Calonje E. T-cell-rich angiomatoid polypoid pseudolymphoma of the skin: a clinicopathologic study of 17 cases and a proposed nomenclature. J Cutan Pathol. 2011;38(6):475-482.
Kaddu S, Cerroni L, Pilatti A, Soyer HP, Kerl H. Acral pseudolymphomatous angiokeratoma. A variant of the cutaneous pseudolymphomas. Am J Dermatopathol. 1994;16(2):130-133.
Okada M, Funayama M, Tanita M, Kudoh K, Aiba S, Tagami H. Acral angiokeratoma-like pseudolymphoma: one adolescent and two adults. J Am Acad Dermatol. 2001;45(6 Suppl):S209-S211.
Wagner G, Rose C, Sachse MM. Papular pseudolymphoma of adults as a variant of acral pseudolymphomatous angiokeratoma of children (APACHE). J Dtsch Dermatol Ges. 2014;12(5):423-424.
Hsiao PF, Wu YH. Angioplasmocellular hyperplasia: a clinicopathologic study of 10 patients. J Am Acad Dermatol. 2011;64(3):542-547.
Gilliam AC, Mullen RH, Oviedo G, et al. Isolated benign primary cutaneous plasmacytosis in children: two illustrative cases. Arch Dermatol. 2009;145(3):299-302.
Fried I, Wiesner T, Cerroni L. Pretibial lymphoplasmacytic plaque in children. Arch Dermatol. 2010;146(1):95-96.
Moulonguet I, Hadj-Rabia S, Gounod N, Bodemer C, Fraitag S. Tibial lymphoplasmacytic plaque: a new, illustrative case of a recently and poorly recognized benign lesion in children. Dermatology. 2012;225(1):27-30.
Uhara H, Saida T, Ikegawa S, et al. Primary cutaneous plasmacytosis: report of three cases and review of the literature. Dermatology. 1994;189(3):251-255.
Honda R, Cerroni L, Tanikawa A, Ebihara T, Amagai M, Ishiko A. Cutaneous plasmacytosis: report of 6 cases with or without systemic involvement. J Am Acad Dermatol. 2013;68(6):978-985.
Wagner G, Rose C, Klapper W, Sachse MM. Cutaneous and systemic plasmocytosis. J Dtsch Dermatol Ges. 2013;11(12):1161-1167.
Adler BL, Krausz AE, Minuti A, Silverberg JI, Lev-Tov H. Epidemiology and treatment of angiolymphoid hyperplasia with eosinophilia (ALHE): a systematic review. J Am Acad Dermatol. 2016;74(3):506-512. e511.
Olsen TG, Helwig EB. Angiolymphoid hyperplasia with eosinophilia. A clinicopathologic study of 116 patients. J Am Acad Dermatol. 1985;12(5 Pt 1):781-796.
Chim CS, Fung A, Shek TW, Liang R, Ho WK, Kwong YL. Analysis of clonality in Kimura's disease. Am J Surg Pathol. 2002;26(8):1083-1086.
Kempf W, Haeffner AC, Zepter K, et al. Angiolymphoid hyperplasia with eosinophilia: evidence for a T-cell lymphoproliferative origin. Hum Pathol. 2002;33(10):1023-1029.
Ofuji S, Furukawa F, Miyachi Y, Ohno S. Papuloerythroderma. Dermatology. 1984;169(3):125-130.
Sugita K, Kabashima K, Nakamura M, Tokura Y. Drug-induced papuloerythroderma: analysis of T-cell populations and a literature review. Acta Derm Venereol. 2009;89(6):618-622.
Torchia D, Miteva M, Hu S, Cohen C, Romanelli P. Papuloerythroderma 2009: two new cases and systematic review of the worldwide literature 25 years after its identification by Ofuji et al. Dermatology. 2010;220(4):311-320.
Shah M, Reid WA, Layton AM. Cutaneous T-cell lymphoma presenting as papuloerythroderma--a case and review of the literature. Clin Exp Dermatol. 1995;20(2):161-163.
Aste N, Fumo G, Conti B, Biggio P. Ofuji papuloerythroderma. J Eur Acad Dermatol Venereol. 2000;14(1):55-57.
Bech-Thomsen N, Thomsen K. Ofuji's papuloerythroderma: a study of 17 cases. Clin Exp Dermatol. 1998;23(2):79-83.
Abeck D, Ollert MW, Eckert F, et al. Palpable migratory arciform erythema. Clinical morphology, histopathology, immunohistochemistry, and response to treatment. Arch Dermatol. 1997;133(6):763-766.
Remy-Leroux V, Leonard F, Lambert D, et al. Comparison of histopathologic-clinical characteristics of Jessner's lymphocytic infiltration of the skin and lupus erythematosus tumidus: multicenter study of 46 cases. J Am Acad Dermatol. 2008;58(2):217-223.
Wagner G, Bartsch S, Rose C, Sachse MM. Palpable arciforme migratory erythema. Hautarzt. 2012;63(12):965-968.
Poenitz N, Dippel E, Klemke CD, Qadoumi M, Goerdt S. Jessner's lymphocytic infiltration of the skin: a CD8+ polyclonal reactive skin condition. Dermatology. 2003;207(3):276-284.
Riveiro-Falkenbach E, Fernandez-Figueras MT, Rodriguez-Peralto JL. Benign atypical intravascular CD30(+) T-cell proliferation: a reactive condition mimicking intravascular lymphoma. Am J Dermatopathol. 2013;35(2):143-150.
Kempf W, Keller K, John H, Dommann-Scherrer C. Benign atypical intravascular CD30+ T-cell proliferation: a recently described reactive lymphoproliferative process and simulator of intravascular lymphoma: report of a case associated with lichen sclerosus and review of the literature. Am J Clin Pathol. 2014;142(5):694-699.
Calamaro P, Cerroni L. Intralymphatic proliferation of T-cell lymphoid blasts in the setting of hidradenitis suppurativa. Am J Dermatopathol. 2016;38(7):536-540.
Kailas A, Elston DM, Crater SE, Cerruto CA. Cutaneous intravascular CD30+ T-cell pseudolymphoma occurring in a regressing keratoacanthoma. J Cutan Pathol. 2018;45(4):296-298.
Samols MA, Su A, Ra S, et al. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30 positive lymphoproliferative disorders. Am J Surg Pathol. 2014;38(9):1203-1211.